Page 74 - Manual of Equine Field Surgery
P. 74
70 LilYIB SURGERIES
' .
\
Figure 10-6 The annular ligament can also be
transected with scissors. A, A small subcutaneous
plane is created for one blade of the scissors, and
B, the annular ligament is transected by closing
the blades of a scissors passed so that one blade of
the scissors is deep to the annular ligament and
the other blade is superficial to the ligament i11 the
subcutaneous plane created.
1.:• ,..,_ . ,. ·.!'·
.,,,, f:U.i~.J·~
B
POSTOPERATIVE CARE
; f d,1~.toperative (are
.
Bandaging: A sterile dressing is placed over the phenylbutazone therapy is. dictated by underlying
incision and a half limb bandage is applied. The tendon damage and the level of lameness present.
initial bandage is changed 24 hours after surgery. Antibiotic therapy is continued in cases with preex-
Subsequent bandage changes are performed at 4- isting infection and in select cases where delayed
to 5-day intervals or more frequently if indicated. incisional healing is anticipated.
Bandaging is applied for a minimum of 4 weeks Suture Removal: Skin sutures are removed
regardless of whether the open or closed technique 12 days postoperatively.
is performed. lntrasynovial Medications: lntrasynovial so-
Exercise Restridions: Stall rest is provided for 1 O dium hyaluronate is a useful adjunctive therapy
days, after which a gradual increase in daily hand- in cases where adhesions have b.een transected
walking is important to minimize adhesion forma- or a high level of inflammation is present within
tion. In cases without underlying tendon pathology, the sheath. Although sodium hyaluronate has
light daily lunging at a trot or limited small paddock been shown in an experimental adhesion model
turnout may be performed 3 weeks postoperatively. to decrease adhesion formation and increase
3
Gradual return to work may begin in 6 weeks or as hyaluronic acid content within the digital sheath,
indicated by the healing of any underlying tendon no products are specifically labeled for digital
. .
lOJUry. sheath use. The author has used 20 to 40 mg
Medications: Phenylbutazone is administered at of sodium hyaluronate labeled for intraarticular
4.4 mg/kg BID for the initial 24 hours and at use at the time of surgery and 10 to 14 days
2.2 mg/kg BID for an additional 5 days. Further postoperatively.
EXPECTED OUTCOME lesions can also have a good prognosis, but exten-
sive tendon lesions or significant sheath adhesions
limit future soundness. The prognosis is guarded
After desmotomy, the lower limb profile has
mild to moderate symmetrical enlargement for cases with septic tenosynovitis.
resulting from release of the constricting liga-
ment. This decreases over time, but it is rare COMPLICATIONS
for a completely normal cosmetic appearance to
return. The prognosis for soundness is good for Complications include wound dehiscence, septic
cases with primary constriction or thickening of tenosynovitis, synovial fistula formation, and
the annular ligament. Cases with minor tendon adhesions. Complications are rare following the